Growth differentiation factor 6, a repressive target of EZH2, promotes the commitment of human embryonic stem cells to mesenchymal stem cells

Abstract

Mesenchymal stem cells (MSCs) derived from human embryonic stem cells (hESCs) have significant potential for cell-mediated bone regeneration. Our recent study revealed that inhibiting the epigenetic regulator EZH2 plays a key role in promoting the mesodermal differentiation of hESCs. In this study, an epigenome-wide analysis of hESCs and MSCs revealed that growth differentiation factor 6 (GDF6), which is involved in bone formation, was the most upregulated gene associated with MSCs compared to hESCs. Furthermore, we identified GDF6 as a repressive target of EZH2 and found that ectopic GDF6 selectively promoted hESC differentiation towards the mesodermal lineage and enriched the MSC population. Our results provide molecular insights governing the mesenchymal commitment of hESCs and identify an inducing factor that offers strong promise for the future of regenerative medicine.

References

[1] Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell, 2008, 2:313-319

[2] Kode JA, Mukherjee S, Joglekar MV, Hardikar AA. Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Cytotherapy, 2009, 11:377-391

[3] Stappenbeck TS, Miyoshi H. The role of stromal stem cells in tissue regeneration and wound repair. Science, 2009, 324:1666-1669

[4] Zhang X et al. Isolation and characterization of mesenchymal stem cells from human umbilical cord blood: reevaluation of critical factors for successful isolation and high ability to proliferate and differentiate to chondrocytes as compared to mesenchymal stem cells from bone marrow and adipose tissue. J. Cell. Biochem., 2011, 112:1206-1218

[5] Koç ON et al. Bone marrow derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases. Exp. Hematol., 1999, 27:1675-1681

[6] Alvarez R, Lee H-L, Wang C-Y, Hong C. Characterization of the osteogenic potential of mesenchymal stem cells from human periodontal ligament based on cell surface markers. Int. J. Oral. Sci., 2015, 7:213-219

[7] Bunnell BA, Flaat M, Gagliardi C, Patel B, Ripoll C. Adipose-derived stem cells: isolation, expansion and differentiation. Methods, 2008, 45:115-120

[8] Gadkari R, Zhao L, Teklemariam T, Hantash BM. Human embryonic stem cell derived-mesenchymal stem cells: an alternative mesenchymal stem cell source for regenerative medicine therapy. Regen. Med., 2014, 9:453-465

[9] Li O et al. Human embryonic stem cell-derived mesenchymal stroma cells (hES-MSC) share basic properties with bone marrow MSC, they have potent stroma support capacities but lack immune-modulatory function. Implications for off-the shelf ES-MSC therapies. Blood, 2010, 116:3858

[10] Barberi T, Willis LM, Socci ND, Studer L. Derivation of multipotent mesenchymal precursors from human embryonic stem cells. PLoS Med., 2005, 2

[11] Trivedi P, Hematti P. Simultaneous generation of CD34⁺ primitive hematopoietic cells and CD73⁺ mesenchymal stem cells from human embryonic stem cells cocultured with murine OP9 stromal cells. Exp. Hematol., 2007, 35:146-154

[12] Olivier EN, Rybicki AC, Bouhassira EE. Differentiation of human embryonic stem cells into bipotent mesenchymal stem cells. Stem Cells, 2006, 24:1914-1922

[13] Xie W et al. Epigenomic analysis of multilineage differentiation of human embryonic stem cells. Cell, 2013, 153:1134-1148

[14] Young RA. Control of the embryonic stem cell state. Cell, 2011, 144:940-954

[15] Collinson A et al. Deletion of the polycomb-group protein EZH2 leads to compromised self-renewal and differentiation defects in human embryonic stem cells. Cell Rep., 2016, 17:2700-2714

[16] Yu Y et al. Inhibition of EZH2 promotes human embryonic stem cell differentiation into mesoderm by reducing H3K27me3. Stem Cell Rep., 2017, 9:752-761

[17] Wei A et al. Expression of growth differentiation factor 6 in the human developing fetal spine retreats from vertebral ossifying regions and is restricted to cartilaginous tissues. J. Orthop. Res., 2016, 34:279-289

[18] Drage Berentsen R, Haukanes BI, Júlíusson PB, Rosendahl K, Houge G. A novel GDF6 mutation in a family with multiple synostoses syndrome without hearing loss. Mol. Syndromol., 2019, 9:228-234

[19] Tassabehji M et al. Mutations in GDF6 are associated with vertebral segmentation defects in Klippel-Feil syndrome. Hum. Mutat., 2008, 29:1017-1027

[20] Settle SH Jr. et al. Multiple joint and skeletal patterning defects caused by single and double mutations in the mouse Gdf6 and Gdf5 genes. Dev. Biol., 2003, 254:116-130

[21] Clendenning DE, Mortlock DP. The BMP ligand Gdf6 prevents differentiation of coronal suture mesenchyme in early cranial development. PLoS ONE, 2012, 7

[22] Thomson JA et al. Embryonic stem cell lines derived from human blastocysts. Science, 1998, 282:1145-1147

[23] Sato N, Meijer L, Skaltsounis L, Greengard P, Brivanlou AH. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat. Med., 2004, 10:55-63

[24] Bakre MM et al. Generation of multipotential mesendodermal progenitors from mouse embryonic stem cells via sustained Wnt pathway activation. J. Biol. Chem., 2007, 282:31703-31712

[25] Pieters T, van Roy F. Role of cell–cell adhesion complexes in embryonic stem cell biology. J. Cell Sci., 2014, 127:2603-2613

[26] Watabe T, Miyazono K. Roles of TGF-beta family signaling in stem cell renewal and differentiation. Cell Res., 2009, 19:103-115

[27] Li W, Wei W, Ding S. TGF-beta signaling in stem cell regulation. Methods Mol. Biol., 2016, 1344:137-145

[28] Xu R-H et al. BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nat. Biotech., 2002, 20:1261-1264

[29] Dale TP et al. Tenogenic differentiation of human embryonic stem cells. Tissue Eng. Part A, 2018, 24:361-368

[30] Hanel ML, Hensey C. Eye and neural defects associated with loss of GDF6. BMC Dev. Biol., 2006, 6:43

[31] Bademci G et al. Long-range cis-regulatory elements controlling GDF6 expression are essential for ear development. J Clin Investig, 2020, 130:4213-4217

[32] Jiang D, Gao P, Zhang Y, Yang S. Combined effects of engineered tendon matrix and GDF-6 on bone marrow mesenchymal stem cell-based tendon regeneration. Biotechnol. Lett., 2016, 38:885-892

[33] Mikic B, Rossmeier K, Bierwert L. Identification of a tendon phenotype in GDF6 deficient mice. Anat. Rec., 2009, 292:396-400

[34] Lee TI et al. Control of developmental regulators by polycomb in human embryonic stem cells. Cell, 2006, 125:301-313

[35] Ram O et al. Combinatorial patterning of chromatin regulators uncovered by genome-wide location analysis in human cells. Cell, 2011, 147:1628-1639

[36] Vodyanik MA et al. A mesoderm-derived precursor for mesenchymal stem and endothelial cells. Cell Stem Cell, 2010, 7:718-729

[37] Chang J et al. Inhibition of osteoblastic bone formation by nuclear factor-kappaB. Nat. Med., 2009, 15:682-689

[38] Deng P, Zhou C, Alvarez R, Hong C, Wang C-Y. Inhibition of IKK/NF-κB signaling enhances differentiation of mesenchymal stromal cells from human embryonic stem cells. Stem Cell Rep., 2016, 6:456-465

Funding

U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research (NIDCR)(R01DE016513)